Saturday, May 29th, 2010 - Alchemy Equities
Biodental Remin Limited announces it has agreed to the first stages of a partnership with Group Pharmaceuticals Ltd of Bangalore, India.

Group Pharma is a medium-sized Indian pharmaceutical company that specialises in the manufacture and distribution of products for dental and oral care.They currently have more than 250 sales representatives directly meeting more than 60,000 dentists each month; their oral hygiene products are sold through some 85,000 retail outlets. They already manufacture products for some well-known dental and oral hygiene companies. Biodental Remin has the technical know how to manufacture Enamelguard - a material that is tasteless and water soluble, with wide application in oral hygiene, confectionary, beverage, nutraceutical and pet care industries.

Biodental also intend using Enamelguard in their own line of dental professional and oral health care products.

Group Pharma intends using Enamelguard in the manufacture and sale within India of professional dental and consumer-level oral-hygiene products for remineralising teeth.

Group Pharma can also assist in facilitating low cost clinical studies and research.

Biodental Remin will also be able to exclusively access Group Pharma's low-cost production centres for the manufacture of BDR's mass-market products to be sold elsewhere.

Tim Erskine-Smith, Managing Director of Biodental Remin, said that he welcomed the partnership with Group Pharma and that he was delighted to have such strong support from a large and influential pharmaceutical company at this early stage of the company's development.

Contact Profile

Kate Ingham

P: +1300 308 882
W: www.biodentalremin.com

Keywords

Biodental, Remin, pharmaceuticals, partnership, Group Pharmaceuticals Ltd.

Categories

Sharing

More Formats